Silo Pharma, Inc. SEC filings SILO

Silo Pharma, Inc. has 378 filings in SEC EDGAR's recent list, going back to Mar 30, 2011. Its latest annual report, Form ARS, was filed on Jun 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 14, 2026 (material agreement, unregistered share sale). The company's fiscal year ends on December 31.

Silo Pharma, Inc. SEC filings
Form Description Filed Period
8-K Current report
Material agreement, Unregistered share sale
Oct 14, 2026 Oct 13, 2026
8-K Current report
Material agreement, Unregistered share sale
Oct 2, 2026 Oct 1, 2026
8-K Current report
Material agreement, Unregistered share sale
Aug 19, 2026 Aug 18, 2026
8-K Current report
Bylaw or fiscal year change, Shareholder vote results
Aug 17, 2026 Aug 14, 2026
10-Q Quarterly report Aug 13, 2026 Jun 30, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 13, 2026 —
EFFECT Filing Aug 6, 2026 —
424B3 Prospectus Aug 6, 2026 —
S-8 Employee stock plan registration Jul 31, 2026 —
S-3 Shelf registration Jul 24, 2026 —
D Filing Jul 14, 2026 —
8-K Current report
Material agreement, Unregistered share sale, Other events
Jul 13, 2026 Jul 9, 2026
SCHEDULE 13G Ownership over 5% (passive) Jul 8, 2026 —
ARS Annual report to shareholders Jun 30, 2026 Dec 31, 2025
DEFA14A Additional proxy material Jun 30, 2026 —
DEF 14A Proxy statement Jun 30, 2026 Aug 14, 2026
8-K Current report
Other events
Jun 18, 2026 Jun 17, 2026
PRE 14A Preliminary proxy statement Jun 18, 2026 Aug 14, 2026
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change, Other events
Jun 3, 2026 Jun 1, 2026
8-K Current report
Other events
Jun 1, 2026 Jun 1, 2026
10-Q Quarterly report May 14, 2026 Mar 31, 2026
424B3 Prospectus Apr 16, 2026 —
EFFECT Filing Apr 15, 2026 —
424B3 Prospectus Apr 14, 2026 —
POS AM Post-effective amendment no. 1 to form s-1 Apr 14, 2026 —
EFFECT Filing Apr 13, 2026 —
POS AM Post-effective amendment no. 2 to form s-1 Apr 10, 2026 —
8-K Current report
Material agreement, Unregistered share sale
Apr 2, 2026 Mar 30, 2026
10-K Annual report Mar 27, 2026 Dec 31, 2025
8-K Current report
Unregistered share sale, Other events
Feb 23, 2026 Feb 20, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 17, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 13, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 13, 2026 —
8-K Current report
Listing notice
Dec 29, 2025 Dec 24, 2025
4 Insider transaction Dec 16, 2025 Dec 15, 2025
EFFECT Filing Nov 26, 2025 —
424B3 Prospectus Nov 26, 2025 —
CORRESP Letter to the SEC Nov 24, 2025 —
4 Insider transaction Nov 21, 2025 Nov 20, 2025
4 Insider transaction Nov 20, 2025 Nov 18, 2025
SCHEDULE 13G Ownership over 5% (passive) Nov 14, 2025 —
10-Q Quarterly report Nov 13, 2025 Sep 30, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 7, 2025 —
S-1 Registration statement Oct 29, 2025 —
8-K Current report
Officer or director change, Shareholder vote results
Oct 24, 2025 Oct 24, 2025
SCHEDULE 13G Ownership over 5% (passive) Oct 3, 2025 —
8-K Current report
Material agreement, Unregistered share sale, Other events
Oct 1, 2025 Sep 29, 2025
424B5 Prospectus supplement Oct 1, 2025 —
DEFA14A Additional proxy material Sep 5, 2025 —
ARS Annual report to shareholders Sep 5, 2025 Dec 31, 2024
DEF 14A Proxy statement Sep 5, 2025 Oct 24, 2025
PRE 14A Preliminary proxy statement Aug 25, 2025 Aug 25, 2025
424B5 Prospectus supplement Aug 18, 2025 —
10-Q Quarterly report Aug 13, 2025 Jun 30, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 12, 2025 —
8-K Current report
Other events
Aug 5, 2025 Aug 4, 2025
8-K Current report
Material agreement, Unregistered share sale, Other events
Jul 29, 2025 Jul 29, 2025
8-K Current report
Material agreement
Jul 10, 2025 Jul 8, 2025
8-K Current report
Listing notice
Jul 3, 2025 Jun 27, 2025
4 Insider transaction May 28, 2025 May 27, 2025
4 Insider transaction May 27, 2025 May 23, 2025
4 Insider transaction May 27, 2025 May 23, 2025
4 Insider transaction May 27, 2025 May 23, 2025
4 Insider transaction May 27, 2025 May 23, 2025
4 Insider transaction May 27, 2025 May 23, 2025
SCHEDULE 13G Ownership over 5% (passive) May 21, 2025 —
8-K Current report
Material agreement, Other events
May 16, 2025 May 15, 2025
424B4 Prospectus May 16, 2025 —
EFFECT Filing May 15, 2025 —
CORRESP Letter to the SEC May 12, 2025 —
S-1/A Amended registration statement May 9, 2025 —
10-Q Quarterly report May 9, 2025 Mar 31, 2025
CORRESP Letter to the SEC Apr 30, 2025 —
S-1/A Amended registration statement Apr 29, 2025 —
CORRESP Letter to the SEC Apr 28, 2025 —
S-1 Registration statement Apr 25, 2025 —
UPLOAD Letter from the SEC Apr 17, 2025 —
DRS Filing Apr 11, 2025 —
424B3 Prospectus Apr 4, 2025 —
EFFECT Filing Apr 3, 2025 —
POS AM Post-effective amendment to form s-1 Mar 28, 2025 —
10-K Annual report Mar 28, 2025 Dec 31, 2024
8-K Current report
Regulation FD disclosure, Other events
Mar 10, 2025 Mar 10, 2025
8-K Current report
Other events
Mar 7, 2025 Mar 4, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 13, 2025 —
8-K Current report
Other events
Jan 2, 2025 Jan 2, 2025
8-K Current report
Shareholder vote results
Dec 20, 2024 Dec 20, 2024
4 Insider transaction Dec 16, 2024 Dec 13, 2024
4 Insider transaction Nov 22, 2024 Nov 20, 2024
DEFR14A Proxy statement Nov 15, 2024 —
SCHEDULE 13G Ownership over 5% (passive) Nov 13, 2024 —
10-Q Quarterly report Nov 12, 2024 Sep 30, 2024
DEFA14A Additional proxy material Nov 8, 2024 —
8-K Current report
Other events
Nov 8, 2024 Nov 8, 2024
ARS Annual report to shareholders Sep 18, 2024 Dec 31, 2023
DEFA14A Additional proxy material Sep 18, 2024 —
DEF 14A Proxy statement Sep 18, 2024 Nov 12, 2024
8-K Current report
Regulation FD disclosure, Other events
Sep 10, 2024 Sep 10, 2024
424B3 Prospectus Sep 4, 2024 —
EFFECT Filing Sep 3, 2024 —
CORRESP Letter to the SEC Aug 29, 2024 —
UPLOAD Letter from the SEC Aug 28, 2024 —
S-1 Registration statement Aug 21, 2024 —
10-Q Quarterly report Aug 13, 2024 Jun 30, 2024
D Filing Aug 2, 2024 —
424B3 Prospectus Jul 31, 2024 —
EFFECT Filing Jul 30, 2024 —
SC 13G Ownership over 5% (passive) Jul 26, 2024 —
CORRESP Letter to the SEC Jul 26, 2024 —
S-1/A Amended registration statement Jul 25, 2024 —
8-K Current report
Material agreement, Unregistered share sale, Other events
Jul 22, 2024 Jul 18, 2024
UPLOAD Letter from the SEC Jul 22, 2024 —
424B5 Prospectus supplement Jul 22, 2024 —
S-1 Registration statement Jul 17, 2024 —
8-K Current report
Material agreement, Other events
Jul 8, 2024 Jul 1, 2024
8-K Current report
Material agreement
Jun 27, 2024 Jun 26, 2024
SC 13G Ownership over 5% (passive) Jun 13, 2024 —
4 Insider transaction Jun 13, 2024 Jun 11, 2024
D Filing Jun 11, 2024 —
8-K Current report
Material agreement, Unregistered share sale, Other events
Jun 6, 2024 Jun 4, 2024
424B5 Prospectus supplement Jun 6, 2024 —
8-K Current report
Other events
Jun 4, 2024 Jun 4, 2024
10-Q Quarterly report May 13, 2024 Mar 31, 2024
4 Insider transaction Apr 8, 2024 Apr 4, 2024
8-K Current report
Other events
Apr 5, 2024 Apr 4, 2024
4 Insider transaction Apr 1, 2024 Mar 28, 2024
10-K Annual report Mar 25, 2024 Dec 31, 2023
8-K Current report
Other events
Feb 1, 2024 Feb 1, 2024
EFFECT Filing Jan 30, 2024 —
CORRESP Letter to the SEC Jan 26, 2024 —
S-3/A Amendment no. 1 to form s-3 Jan 25, 2024 —
SC 13G/A Amended ownership over 5% (passive) Jan 25, 2024 —
UPLOAD Letter from the SEC Jan 25, 2024 —
S-3 Shelf registration Jan 23, 2024 —
8-K/A Amended current report
Other events
Jan 11, 2024 Jan 9, 2024
8-K Current report
Other events
Jan 9, 2024 Jan 9, 2024
4 Insider transaction Dec 21, 2023 Dec 19, 2023
8-K12B Current report Dec 20, 2023 Dec 19, 2023
4 Insider transaction Dec 18, 2023 Dec 14, 2023
8-K Current report
Shareholder vote results
Dec 11, 2023 Dec 11, 2023
4 Insider transaction Dec 7, 2023 Dec 5, 2023
8-K Current report
Bylaw or fiscal year change, Other events
Dec 5, 2023 Dec 4, 2023
8-K Current report
Shareholder vote results
Dec 4, 2023 Dec 4, 2023
4 Insider transaction Nov 30, 2023 Nov 29, 2023
4 Insider transaction Nov 27, 2023 Nov 22, 2023
4 Insider transaction Nov 22, 2023 Nov 20, 2023
4 Insider transaction Nov 20, 2023 Nov 16, 2023
8-K Current report
Material agreement
Nov 14, 2023 Nov 10, 2023
10-Q Quarterly report Nov 13, 2023 Sep 30, 2023
DEFA14A Additional proxy material Oct 23, 2023 —
DEF 14A Proxy statement Oct 23, 2023 Dec 4, 2023
PRE 14A Preliminary proxy statement Oct 10, 2023 Dec 4, 2023
8-K Current report
Other events
Aug 31, 2023 Aug 25, 2023
10-Q Quarterly report Aug 11, 2023 Jun 30, 2023
8-K Current report
Other events
Jun 29, 2023 Jun 28, 2023
4 Insider transaction May 26, 2023 May 26, 2023
4 Insider transaction May 18, 2023 May 17, 2023
10-Q Quarterly report May 12, 2023 Mar 31, 2023
8-K Current report
Other events
Mar 27, 2023 Mar 27, 2023
10-K Annual report Mar 24, 2023 Dec 31, 2022
8-K Current report
Other events
Feb 15, 2023 Feb 13, 2023
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2023 —
8-K Current report
Other events
Feb 3, 2023 Feb 2, 2023
8-K Current report
Other events
Jan 31, 2023 Jan 31, 2023
8-K Current report
Other events
Jan 20, 2023 Jan 15, 2023
4 Insider transaction Dec 20, 2022 Dec 19, 2022
4 Insider transaction Dec 15, 2022 Dec 13, 2022
8-K Current report
Other events
Dec 1, 2022 Dec 1, 2022
SC 13G Ownership over 5% (passive) Nov 16, 2022 —
10-Q Quarterly report Nov 10, 2022 Sep 30, 2022
8-K Current report
Material agreement, Officer or director change, Regulation FD disclosure, Other events
Oct 18, 2022 Oct 12, 2022
3 Initial insider ownership Oct 4, 2022 Sep 27, 2022
3 Initial insider ownership Oct 4, 2022 Sep 27, 2022
8-K Current report
Material agreement, Officer or director change, Other events
Sep 30, 2022 Sep 26, 2022
424B4 Prospectus Sep 28, 2022 —
CERT 8a cert Sep 27, 2022 —
EFFECT Filing Sep 26, 2022 —
8-A12B For registration of certain classes Sep 26, 2022 —
CORRESP Letter to the SEC Sep 22, 2022 —
CORRESP Letter to the SEC Sep 22, 2022 —
S-1/A Amended registration statement Sep 20, 2022 —
8-K Current report
Bylaw or fiscal year change, Other events
Sep 15, 2022 Sep 14, 2022
S-1/A Amended registration statement Sep 9, 2022 —
S-1/A Amended registration statement Aug 29, 2022 —
10-Q Quarterly report Aug 1, 2022 Jun 30, 2022
S-1/A Amended registration statement Jul 25, 2022 —
4 Insider transaction Jun 21, 2022 Jun 17, 2022
10-Q Quarterly report May 13, 2022 Mar 31, 2022
10-K Annual report Mar 28, 2022 Dec 31, 2021
8-K Current report
Shareholder vote results
Mar 11, 2022 Mar 11, 2022
DEFA14A Additional proxy material Mar 7, 2022 —
8-K Current report
Other events
Mar 7, 2022 Mar 7, 2022
DEF 14A Proxy statement Feb 14, 2022 Mar 11, 2022
PRE 14A Preliminary proxy statement Feb 2, 2022 Feb 2, 2022
4/A Ownership document Jan 5, 2022 Dec 29, 2021
8-K Current report
Officer or director change
Jan 4, 2022 Dec 29, 2021
4 Insider transaction Jan 3, 2022 Dec 29, 2021
4 Insider transaction Jan 3, 2022 Dec 29, 2021
UPLOAD Letter from the SEC Dec 15, 2021 —
4 Insider transaction Dec 15, 2021 Dec 10, 2021

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
SILO (Nasdaq)
Fiscal year ends
December 31
Incorporated in
NV
Headquarters
Sarasota, FL
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1514183
Former names
Uppercut Brands, Inc. (until Aug 14, 2020); Point Capital, Inc. (until May 14, 2019); Gold Swap Inc (until Jan 7, 2013)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.